As of April 15, Novozymes has purchased an accumulated 1,766,346 shares with a
transaction value of DKK 510.2 million under the stock buyback program
Novozymes announced in Company announcement No. 2, 2016 and initiated February
1, 2016. Under the program, Novozymes will buy back B shares worth up to DKK 2
billion in total during 2016.
Read the full announcement in PDF